Current filters:  
United States
Life Sciences, Biotechnology & Nanotechnology
European Union
Cooley LLP
The extraordinary times we find ourselves in during the global COVID-19 crisis has led to extraordinary measures being taken by product manufacturers and suppliers across the globe.
The background on the EC's initial response to the outbreak and its adoption of the Temporary Framework were previously summarized in our prior client alert.
United States
Reed Smith
This Wednesday evening marks the beginning of the Jewish holiday of Passover.
Pryor Cashman LLP
The recently enacted Public Readiness and Emergency Preparedness Act ("PREP Act") provides immunity from tort liability claims (except for willful misconduct) to individuals and organizations involved in the manufacture...
Buchanan Ingersoll & Rooney PC
The world is facing a health crisis at a level it has not experienced in generations. The U.S. and countries worldwide are grappling with how to best protect citizens in the wake of the transmission of the SARS-CoV-2 virus ...
Morrison & Foerster LLP
Last week, the U.S. Food and Drug Administration (FDA) took yet another step to encourage production of basic medical supplies in the battle against COVID-19.
Holland & Knight
This month, the U.S. Court of Appeals for the Federal Circuit has handed down a pair of opinions concerning Section 101 in the field of pharmaceuticals and life sciences...
Morrison & Foerster LLP
COVID-19 is, quite literally, putting the medical supply industry to the test. Manufacturers are being pushed to develop novel products like therapies and vaccines
Fenwick & West LLP
The global spread of COVID-19 has impacted all aspects of business and raises significant securities law questions for public life sciences companies.
Arnold & Porter
This quarterly newsletter provides updates on litigation, regulatory, legislative, and other notable developments involving chemicals of concern to business.
Arnold & Porter
The primary legislation governing the authorisation, marketing, sale and supply of pharmaceutical products by the US Food and Drug Administration (FDA)
Arnold & Porter
Despite early high expectations for the role telehealth would play in the US health care delivery system, utilization of telehealth services has--until recently--been relatively modest.
Shipman & Goodwin LLP
We know that right now most providers are in great need of N95 masks and other personal protective equipment ("PPE").
Morrison & Foerster LLP
The rapid spread of coronavirus has spawned prolific marketing claims that any number of products can treat or prevent coronavirus.
Arnold & Porter
In the midst of this coronavirus crisis, many of our friends and colleagues are bravely working in support of the nationwide mobilization now under way.
Reed Smith
We are just going to dive right into it today. Because in a world where the rules and the situation are in such a state of flux and unknown, a little taste of something familiar is reassuring.
Sheppard Mullin Richter & Hampton
The U.S. Food and Drug Administration (FDA) issued two Emergency Use Authorizations (EUA) for commercially distributed COVID-19 diagnostic tests at the end of last week.
Shipman & Goodwin LLP
Here is a current list of "essential services and goods" under Executive Order 7H. We will update as more guidance becomes available:
Duane Morris LLP
As concerns surrounding coronavirus (COVID-19) escalate, U.S. trade policy is aligning with the country's medical needs.
Arnold & Porter
As COVID-19 spreads across the globe, some of the countries hit hardest by the virus or at grave risk, including Iran and Syria, are subject to the most stringent US economic sanctions.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Popular Authors
Font Size:
Mondaq Social Media